SAT-3247

DRUG3 trials

Sponsors

Satellos Bioscience, Inc.

Conditions

DMDDuchenneDuchenne Muscular DystrophyDuchenne Muscular Dystrophy (DMD)Muscular DystrophiesNeuromuscular Diseases

Early Phase 1

First in Human SAD/MAD Safety and PK Study With Adult DMD Safety and PK Cohort

CompletedNCT06565208

Satellos Bioscience, Inc.Duchenne Muscular Dystrophy

Start: 2024-08-21End: 2025-04-28Updated: 2025-05-15

Phase 2

An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101

Enrolling by invitationNCT06867107

Satellos Bioscience, Inc.Duchenne Muscular Dystrophy (DMD)

Start: 2025-08-20End: 2026-08-30Target: 10Updated: 2026-04-23

Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients

RecruitingNCT07287189

Satellos Bioscience, Inc.DMD, Duchenne, Duchenne Muscular Dystrophy +2

Start: 2025-12-08End: 2028-02-28Target: 51Updated: 2026-09-18